Search
for
Sort by
Research 961–990 of 1000+
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Systemic treatments for alopecia areata: A systematic review
- Assessment of hair loss: clinical relevance of hair growth evaluation methods
- Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic–Pituitary–Adrenocortical Axis Elements and Melanogenesis
- Novel cosmeceuticals from plants—An industry guided review
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Oxidative stress management in the hair follicle: Could targeting NRF2 counter age‐related hair disorders and beyond?
- A novel therapeutic paradigm for patients with extensive alopecia areata
- What does acne genetics teach us about disease pathogenesis?
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Recent advances in the treatment of psoriasis
- Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia
- Gender-Affirming Hormone Therapy for Transgender Men
- Lupus panniculitis clinically simulating alopecia areata
- Immune cell regulation of the hair cycle
- Effect of finasteride in idiopathic hirsutism
- Nonvascular Complications of Injectable Fillers—Prevention and Management
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Stem cells and aberrant signaling of molecular systems in skin aging
- Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Androgenetic alopecia; drug safety and therapeutic strategies
- HAIR MATRIX CELL KINETICS: A SELECTIVE REVIEW
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism